IGF2BP2 and acute lymphoblastic leukemia: Here we found that IGF2BP2 promoted human T-ALL growth, reduced cytarabine (Ara-C)-, vincristine (VCR)-, venetoclax- or dexamethasone (Dex)-induced apoptosis in vitro and is essential for leukemogenesis in vivo.